|
Name |
Phenylacetone
|
Molecular Formula | C9H10O | |
IUPAC Name* |
1-phenylpropan-2-one
|
|
SMILES |
CC(=O)CC1=CC=CC=C1
|
|
InChI |
InChI=1S/C9H10O/c1-8(10)7-9-5-3-2-4-6-9/h2-6H,7H2,1H3
|
|
InChIKey |
QCCDLTOVEPVEJK-UHFFFAOYSA-N
|
|
Synonyms |
Phenylacetone; 1-phenylpropan-2-one; 103-79-7; 1-Phenyl-2-propanone; Benzyl methyl ketone; Methyl benzyl ketone; Phenyl-2-propanone; 1-Phenylacetone; 2-Propanone, 1-phenyl-; 3-Phenyl-2-propanone; Phenylmethyl methyl ketone; phenyl acetone; 1-phenyl-propan-2-one; 136675-26-8; O7IZH10V9Y; CHEMBL3800510; NSC-9827; NSC 9827; Phenylacetone, 99%; EINECS 203-144-4; UNII-O7IZH10V9Y; (phenyl)acetone; AI3-02938; DEA No. 8501; methylbenzyl ketone; phenyl 2-propanone; 1-Phenylpropane-2-one; PHENYLACETONE [MI]; SCHEMBL43943; ghl.PD_Mitscher_leg0.660; DTXSID1059280; SCHEMBL13341529; CHEBI:52052; HSDB 8385; NSC9827; Phenylacetone, analytical standard; BCP22277; ZINC1700205; BDBM50167968; STL373560; AKOS004905656; FT-0673719; A800807; Q418831; AMFETAMINE SULFATE IMPURITY B [EP IMPURITY]
|
|
CAS | 103-79-7 | |
PubChem CID | 7678 | |
ChEMBL ID | CHEMBL3800510 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 134.17 | ALogp: | 1.4 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.607 |
Caco-2 Permeability: | -4.272 | MDCK Permeability: | 0.00004190 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.38 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.479 | Plasma Protein Binding (PPB): | 53.75% |
Volume Distribution (VD): | 0.707 | Fu: | 32.61% |
CYP1A2-inhibitor: | 0.531 | CYP1A2-substrate: | 0.669 |
CYP2C19-inhibitor: | 0.685 | CYP2C19-substrate: | 0.686 |
CYP2C9-inhibitor: | 0.161 | CYP2C9-substrate: | 0.33 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.464 |
CYP3A4-inhibitor: | 0.018 | CYP3A4-substrate: | 0.481 |
Clearance (CL): | 11.192 | Half-life (T1/2): | 0.834 |
hERG Blockers: | 0.031 | Human Hepatotoxicity (H-HT): | 0.507 |
Drug-inuced Liver Injury (DILI): | 0.756 | AMES Toxicity: | 0.024 |
Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.419 | Carcinogencity: | 0.185 |
Eye Corrosion: | 0.705 | Eye Irritation: | 0.978 |
Respiratory Toxicity: | 0.022 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000219 | 0.697 | D07ONP | 0.561 | ||||
ENC000054 | 0.697 | D05OIS | 0.545 | ||||
ENC005854 | 0.697 | D0R1CR | 0.525 | ||||
ENC000208 | 0.686 | D05BMG | 0.514 | ||||
ENC000308 | 0.639 | D0T3LF | 0.514 | ||||
ENC001819 | 0.605 | D0P2GK | 0.500 | ||||
ENC000203 | 0.594 | D0U0RZ | 0.487 | ||||
ENC000216 | 0.590 | D00DZN | 0.477 | ||||
ENC000693 | 0.590 | D0P6UB | 0.475 | ||||
ENC000192 | 0.559 | D0X9RY | 0.472 |